For help on how to get the results you want, see our search tips.
1409 results
Medicine
European public assessment reports (EPAR) Remove European public assessment reports (EPAR) filter
Authorisation status
Authorised Remove Authorised filter
-
List item
Human medicine European public assessment report (EPAR): Tafinlar (updated)
dabrafenib mesylate, Melanoma
Date of authorisation: 26/08/2013, Revision: 22, Authorised, Last updated: 22/01/2021 -
List item
Human medicine European public assessment report (EPAR): Tremfya (updated)
guselkumab, Psoriasis
Date of authorisation: 10/11/2017,
, Revision: 5, Authorised, Last updated: 22/01/2021
-
List item
Human medicine European public assessment report (EPAR): Tasigna (updated)
nilotinib, Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Date of authorisation: 19/11/2007, Revision: 38, Authorised, Last updated: 22/01/2021 -
List item
Human medicine European public assessment report (EPAR): Ervebo (updated)
recombinant vesicular stomatitis virus (strain indiana) with a deletion of the envelope glycoprotein, replaced with the zaire ebolavirus (strain kikwit 1995) surface glycoprotein, Hemorrhagic Fever, Ebola
Date of authorisation: 11/11/2019,, Revision: 2, Authorised, Last updated: 22/01/2021
-
List item
Human medicine European public assessment report (EPAR): Wakix (updated)
pitolisant, Narcolepsy
Date of authorisation: 31/03/2016,, 
, Revision: 9, Authorised, Last updated: 21/01/2021
-
List item
Human medicine European public assessment report (EPAR): Zebinix (updated)
eslicarbazepine acetate, Epilepsy
Date of authorisation: 21/04/2009, Revision: 27, Authorised, Last updated: 21/01/2021 -
List item
Human medicine European public assessment report (EPAR): Mysimba (updated)
bupropion hydrochloride, naltrexone hydrochloride, Obesity, Overweight
Date of authorisation: 26/03/2015,, Revision: 18, Authorised, Last updated: 21/01/2021
-
List item
Human medicine European public assessment report (EPAR): Oncaspar (updated)
pegaspargase, Precursor Cell Lymphoblastic Leukemia-Lymphoma
Date of authorisation: 14/01/2016,, Revision: 12, Authorised, Last updated: 21/01/2021
-
List item
Human medicine European public assessment report (EPAR): Odefsey (updated)
emtricitabine, rilpivirine hydrochloride, tenofovir alafenamide, HIV Infections
Date of authorisation: 21/06/2016, Revision: 17, Authorised, Last updated: 21/01/2021 -
List item
Human medicine European public assessment report (EPAR): Oslif Breezhaler (updated)
indacaterol maleate, Pulmonary Disease, Chronic Obstructive
Date of authorisation: 29/11/2009, Revision: 16, Authorised, Last updated: 20/01/2021 -
List item
Veterinary medicine European public assessment report (EPAR): Bravecto (updated)
fluralaner, Dogs, Cats
Date of authorisation: 11/02/2014, Revision: 13, Authorised, Last updated: 19/01/2021 -
List item
Human medicine European public assessment report (EPAR): Recarbrio (updated)
imipenem monohydrate, cilastatin sodium, relebactam monohydrate, Gram-Negative Bacterial Infections
Date of authorisation: 13/02/2020,, Revision: 1, Authorised, Last updated: 19/01/2021
-
List item
Human medicine European public assessment report (EPAR): Ryzodeg (updated)
insulin aspart, insulin degludec, Diabetes Mellitus
Date of authorisation: 21/01/2013, Revision: 12, Authorised, Last updated: 19/01/2021 -
List item
Human medicine European public assessment report (EPAR): Roteas (updated)
edoxaban tosylate, Stroke, Venous Thromboembolism
Date of authorisation: 19/04/2017,, Revision: 8, Authorised, Last updated: 19/01/2021
-
List item
Human medicine European public assessment report (EPAR): Pradaxa (updated)
Dabigatran etexilate mesilate, Arthroplasty, Replacement, Venous Thromboembolism
Date of authorisation: 17/03/2008,
, Revision: 32, Authorised, Last updated: 19/01/2021
-
List item
Human medicine European public assessment report (EPAR): Cerezyme (updated)
imiglucerase, Gaucher Disease
Date of authorisation: 17/11/1997, Revision: 25, Authorised, Last updated: 18/01/2021 -
List item
Human medicine European public assessment report (EPAR): Ovitrelle (updated)
choriogonadotropin alfa, Anovulation, Reproductive Techniques, Assisted, Infertility, Female
Date of authorisation: 02/02/2001, Revision: 20, Authorised, Last updated: 18/01/2021 -
List item
Human medicine European public assessment report (EPAR): Incruse Ellipta (previously Incruse) (updated)
umeclidinium bromide, Pulmonary Disease, Chronic Obstructive
Date of authorisation: 28/04/2014,, Revision: 14, Authorised, Last updated: 18/01/2021
-
List item
Human medicine European public assessment report (EPAR): Yervoy (updated)
Ipilimumab, Melanoma
Date of authorisation: 12/07/2011, Revision: 35, Authorised, Last updated: 18/01/2021 -
List item
Human medicine European public assessment report (EPAR): Lyxumia (updated)
lixisenatide, Diabetes Mellitus, Type 2
Date of authorisation: 31/01/2013, Revision: 12, Authorised, Last updated: 18/01/2021 -
List item
Human medicine European public assessment report (EPAR): Dificlir (updated)
fidaxomicin, Clostridium Infections
Date of authorisation: 05/12/2011, Revision: 13, Authorised, Last updated: 18/01/2021 -
List item
Human medicine European public assessment report (EPAR): Clopidogrel TAD (updated)
clopidogrel (as hydrochloride), Peripheral Vascular Diseases, Stroke, Myocardial Infarction
Date of authorisation: 23/09/2009,
, Revision: 12, Authorised, Last updated: 18/01/2021
-
List item
Human medicine European public assessment report (EPAR): Bortezomib Fresenius Kabi (updated)
bortezomib, Multiple Myeloma
Date of authorisation: 14/11/2019,, Revision: 3, Authorised, Last updated: 18/01/2021
-
List item
Human medicine European public assessment report (EPAR): Tyverb (updated)
lapatinib, Breast Neoplasms
Date of authorisation: 10/06/2008, Revision: 31, Authorised, Last updated: 15/01/2021 -
List item
Human medicine European public assessment report (EPAR): Toujeo (previously Optisulin) (updated)
insulin glargine, Diabetes Mellitus
Date of authorisation: 26/06/2000, Revision: 31, Authorised, Last updated: 15/01/2021